Dermorphin

$147.26

Dermorphin is a research compound from Pure Rawz, supplied for in-vitro laboratory research. Every order ships clearly labelled with the compound name and size.

For research use only. Not for human or animal consumption.

For laboratory research use only. This product is not for human or animal consumption and is not intended to diagnose, treat, cure or prevent any disease. Sold only to qualified researchers.
SKU: PRZ-359231584 Category:

Description

Dermorphin research peptide

Dermorphin is a heptapeptide first isolated from the skin of South American Phyllomedusa frogs. It contains a D-alanine residue and is a highly potent, selective μ-opioid receptor agonist, used in opioid receptor pharmacology.

Product details

Compound Dermorphin
Class Opioid heptapeptide (μ-opioid receptor agonist)
Strength 10mg
Labelling Compound name and strength on every container

Select your format and strength from the options above.

What Dermorphin research has examined

  • μ-opioid receptor pharmacology: potency and selectivity studies.
  • D-amino acids in nature: one of the first natural peptides found to contain a D-amino acid.
  • Analgesia models: animal pain research.

Research interest does not establish a proven effect in humans.

Regulatory status

Dermorphin is not an approved medicine, it is a potent opioid agonist, and it is prohibited in sport. Supplied strictly as a research chemical for qualified laboratories.

Storage and handling

Store lyophilised vials cold, dry and away from light. Reconstitute with a suitable sterile diluent under aseptic conditions and keep solutions refrigerated. See our peptide reconstitution guide.

Related research products

DY-131 · Oxytocin Spray · CardioCytogen · All peptides

References

For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.

Additional information

Strength

10mg

Reviews

There are no reviews yet.

Be the first to review “Dermorphin”

Your email address will not be published. Required fields are marked *